Cycle control, safety and efficacy of a 24-day regimen of gestodene 60 µg/ethinylestradiol 15 µg and a 21-day regimen of desogestrel 150 µg/ethinylestradiol 20 µg
Gestodene Study Group 324 - The European Journal of …, 1999 - Taylor & Francis
Objectives: This multicenter, open-label study was conducted to compare the cycle control,
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
efficacy and safety of a 24-day regimen of a new ultra-low-dose oral contraceptive …
The safety and contraceptive efficacy of a 24-day low-dose oral contraceptive regimen containing gestodene 60 µg and ethinylestradiol 15 µg
Gestodene Study Group 322 - The European Journal of …, 1999 - Taylor & Francis
Objectives: The safety and contraceptive efficacy of a new 24-day regimen of an oral
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
contraceptive combination containing gestodene (GTD) 60 µg and ethinylestradiol (EE) 15 …
A comparison of the cycle control and tolerability of two ultra low-dose oral contraceptives containing 20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg …
D Serfaty, ML Vree - The European Journal of Contraception & …, 1998 - Taylor & Francis
Objective To compare the cycle control and tolerability of two oral contraceptives containing
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …
20 μg ethinylestradiol and either 150 μg desogestrel or 75 μg gestodene. Methods A …
Prospective, open-label, noncomparative study to assess cycle control, safety and acceptability of a new oral contraceptive containing gestodene 60 μg and …
IC Barbosa, C Isaia Filho, D Faggion Jr, EC Baracat - Contraception, 2006 - Elsevier
OBJECTIVE: A prospective, open-label, noncomparative, multicenter study was carried out
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
in 163 women aged 18–39 (mean 25±5 years), who used an ultra-low-dose oral …
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 …
J Endrikat, U Müller, B Düsterberg - Contraception, 1997 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control, and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
an oral contraceptive containing 20 μg ethinylestradiol (EE2) and 75 μg gestodene (GSD) …
Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a …
J Endrikat, M Cronin, C Gerlinger, A Ruebig, W Schmidt… - Contraception, 2001 - Elsevier
This prospective, open, randomized study was conducted to compare the contraceptive
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …
reliability, cycle control, and tolerability of a 23-day regimen with 20 μg ethinyl estradiol (EE) …
A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol …
J Endrikat, MA Jaques, M Mayerhofer, C Pelissier… - Contraception, 1995 - Elsevier
The aim of this study was to compare contraceptive reliability, cycle control and tolerance of
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …
an oral contraceptive containing 20 μg ethinylestradiol and 75 μg gestodene, with a …
Efficacy, cycle control and side-effects of two monophasic combination oral contraceptives: Gestodene/ethinylestradiol and norgestimate/ethinylestradiol
P Affinito, M Monterubbianesi, M Primizia… - Gynecological …, 1993 - Taylor & Francis
Two monophasic oral contraceptives containing gestodene (GTD, 15 μg) and
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
ethinylestradiol (EE, 30 μg) or norgestimate (NGS, 250 μg) and EE (35 μg) were compared …
A three-year clinical investigation into efficacy, cycle control and tolerability of a new low-dose monophasic oral contraceptive containing gestodene
B Düsterberg, H Ellman, U Müller… - Gynecological …, 1996 - Taylor & Francis
This long-term, open-label, multicenter study investigated the clinical efficacy and tolerability
of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μ ggestodene …
of a monophasic oral contraceptive containing 20 μg ethinylestradiol and 75 μ ggestodene …
A comparison of cycle control and effect on well-being of monophasic gestodene-, triphasic gestodene-and monophasic desogestrel-containing oral contraceptives
P Lacante - Gynecological Endocrinology, 1996 - Taylor & Francis
This was an open-label, multicenter study to compare the cycle control and effect on well-
being of two gestodene-containing and one desogestrel-containing oral contraceptive …
being of two gestodene-containing and one desogestrel-containing oral contraceptive …